Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

The Impact of NOD2/CARD15 and KIR Polymorphisms on the Incidence of Infectious Complications in allo-HSCT Recipients.

Aleksandra Holowiecka-Goral, MD, Sebastian Giebel, MD, Izabela Nowak, PhD, Tomasz Czerw, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Elzbieta Pietruszka, PhD, Miroslaw Markiewicz, MD, Piotr Kusnierczyk, MD, Iwona Wylezol, MD, Jerzy Holowiecki Prof

Blood (2007) 110 (11): 2968.

https://doi.org/10.1182/blood.V110.11.2968.2968

Published: 2007

Journal Articles

Disparities of Minor Histocompatibility Antigens in Unrelated Allo-HCT.

Miroslaw Markiewicz, MD, Urszula Siekiera, Jerzy Wojnar, MD,PhD, Iwona Wylezol, MD, Sebastian Giebel, MD, Monika Dzierzak, MD, Agnieszka Karolczyk, Jerzy Holowiecki, MD,PhD

Blood (2007) 110 (11): 3070.

https://doi.org/10.1182/blood.V110.11.3070.3070

Published: 2007

Journal Articles

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Jerzy Wojnar, MD, Sebastian Giebel, MD, Miroslaw Markiewicz, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Beata Stella-Holowiecka, MD, Tomasz Kruzel, MD, Jerzy Holowiecki

Blood (2006) 108 (11): 5245.

https://doi.org/10.1182/blood.V108.11.5245.5245

Published: 2006

Journal Articles

Beyond HLA: Impact of Immunoreactive Mismatches of Minor Histocompatibility Antigens on Probability of Relapse and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation from HLA-Matched Unrelated Donors.

Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, Dr of Biol Sci, Jerzy Wojnar, MD, Assoc., Agata Wieczorkiewicz, MD, Iwona Wylezol, MD, PhD, Sebastian Giebel, MD, PhD, Agnieszka Karolczyk, Biol., Jerzy Holowiecki, MD

Blood (2006) 108 (11): 3156.

https://doi.org/10.1182/blood.V108.11.3156.3156

Published: 2006

Journal Articles

Impaired Survival after Unrelated Hematopoietic Stem Cell Transplantation from KIR2DS1 and KIR2DS2 Positive Donors.

Sebastian Giebel, MD, Tomasz Czerw, MD, Izabela Nowak, PhD, Jerzy Wojnar, MD, Tomasz Kruzel, MD, Joanna Dziaczkowska, PhD, Miroslaw Markiewicz, MD, Aleksandra Holowiecka-Goral, MD, Agnieszka Karolczyk, PhD, Iwona Wylezol, MD, Piotr Kusnierczyk, PhD, Jerzy Holowiecki

Blood (2006) 108 (11): 3113.

https://doi.org/10.1182/blood.V108.11.3113.3113

Published: 2006

Journal Articles

Treosulfan, Fludarabine, and Antithymocyte Globulin - A Low Toxicity Conditioning Regimen for Unrelated Donor - Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Jerzy Holowiecki, Sebastian Giebel, MD, Jerzy Wojnar, MD, Miroslaw Markiewicz, MD, Aleksandra Holowiecka-Goral, MD, Iwona Wylezol, MD, Malgorzata Krawczyk-Kulis, MD, Krzysztof Wozniczka, MD

Blood (2006) 108 (11): 2948.

https://doi.org/10.1182/blood.V108.11.2948.2948

Published: 2006

Journal Articles

Impact of Activating Killer Immunoglobulin-Receptor Genotype of the Donor on Outcome of Unrelated Donor - Hematopoietic Stem Cell Transplantation.

Sebastian Giebel, MD, Izabela Nowak, PhD, Tomasz Kruzel, MD, Jerzy Wojnar, MD, Miroslaw Markiewicz, MD, Joanna Dziaczkowska, MD, Iwona Wylezol, MD, Malgorzata Krawczyk-Kulis, MD, Renata Bloch, PhD, Tomasz Czerw, MD, Agnieszka Karolczyk, PhD, Piotr Kusnierczyk, PhD, Jerzy Holowiecki

Blood (2005) 106 (11): 5206.

https://doi.org/10.1182/blood.V106.11.5206.5206

Published: 2005

Journal Articles

Treosulfan + Fludarabine +/− Thymoglobulin - An Effective Low Toxicity Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Jerzy Holowiecki, Sebastian Giebel, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Miroslaw Markiewicz, MD, Tomasz Kruzel, MD, Aleksandra Holowiecka-Goral, MD, Malgorzata Kopera, MD

Blood (2005) 106 (11): 5309.

https://doi.org/10.1182/blood.V106.11.5309.5309

Published: 2005

Journal Articles

Multiple Transplant-Related Risk Factors for Hemolysis Including Major Kidd-Group Incompatibility Did Not Influence the Favourable Course of Unrelated Donor Bone Marrow Transplantation for Paroxysmal Nocturnal Hemoglobinuria.

Miroslaw Markiewicz, MD, Iwona Wylezol, MD, Sebastian Giebel, MD, Malgorzata Krawczyk-Kulis, MD, Jerzy Wojnar, MD, Ewa Mendek-Czajkowska, MD, Jerzy Holowiecki

Blood (2005) 106 (11): 5444.

https://doi.org/10.1182/blood.V106.11.5444.5444

Published: 2005

Journal Articles

Impact of HLA Class I Typing-Resolution and Mismatches on Survival and Graft-Versus-Host Disease in Patients after Hematopoietic Stem Cell Transplantations from Unrelated Donors.

Miroslaw Markiewicz, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Sebastian Giebel, MD, Jerzy Holowiecki

Blood (2005) 106 (11): 2060.

https://doi.org/10.1182/blood.V106.11.2060.2060

Published: 2005

Journal Articles

The Impact of Immunosuppressive Therapy on an Early Quantitative Reconstitution of NK Cells after Allogeneic Hematopoietic Stem Cell Transplantation.

Sebastian Giebel, MD, Joanna Dziaczkowska, PhD, Iwona Wylezol, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Krystyna Jagoda, PhD, Aleksandra Holowiecka-Goral, MD, Jerzy Holowiecki

Blood (2004) 104 (11): 4946.

https://doi.org/10.1182/blood.V104.11.4946.4946

Published: 2004

Journal Articles

Treosulfan-Based Myeloablative Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Is Associated with Reduced Toxicity without Increased Risk of Relapse.

Sebastian Giebel, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Miroslaw Markiewicz, MD, Tomasz Kruzel, MD, Jerzy Holowiecki, MD

Blood (2004) 104 (11): 1152.

https://doi.org/10.1182/blood.V104.11.1152.1152

Published: 2004

Journal Articles

Treosulfan/Fludarabine - a Low Toxicity but Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Jerzy Holowiecki, Sebastian Giebel, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Tomasz Kruzel, MD, Miroslaw Markiewicz, MD

Blood (2004) 104 (11): 1022.

https://doi.org/10.1182/blood.V104.11.1022.1022

Published: 2004

NARROW

The Impact of NOD2/CARD15 and KIR Polymorphisms on the Incidence of Infectious Complications in allo-HSCT Recipients.

Disparities of Minor Histocompatibility Antigens in Unrelated Allo-HCT.

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Beyond HLA: Impact of Immunoreactive Mismatches of Minor Histocompatibility Antigens on Probability of Relapse and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation from HLA-Matched Unrelated Donors.

Impaired Survival after Unrelated Hematopoietic Stem Cell Transplantation from KIR2DS1 and KIR2DS2 Positive Donors.

Treosulfan, Fludarabine, and Antithymocyte Globulin - A Low Toxicity Conditioning Regimen for Unrelated Donor - Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Impact of Activating Killer Immunoglobulin-Receptor Genotype of the Donor on Outcome of Unrelated Donor - Hematopoietic Stem Cell Transplantation.

Treosulfan + Fludarabine +/− Thymoglobulin - An Effective Low Toxicity Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Multiple Transplant-Related Risk Factors for Hemolysis Including Major Kidd-Group Incompatibility Did Not Influence the Favourable Course of Unrelated Donor Bone Marrow Transplantation for Paroxysmal Nocturnal Hemoglobinuria.

Impact of HLA Class I Typing-Resolution and Mismatches on Survival and Graft-Versus-Host Disease in Patients after Hematopoietic Stem Cell Transplantations from Unrelated Donors.

The Impact of Immunosuppressive Therapy on an Early Quantitative Reconstitution of NK Cells after Allogeneic Hematopoietic Stem Cell Transplantation.

Treosulfan-Based Myeloablative Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Is Associated with Reduced Toxicity without Increased Risk of Relapse.

Treosulfan/Fludarabine - a Low Toxicity but Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only